The Role of Non-statin Therapy for Secondary Prevention of ASCVD The Role of Non-statin Therapy for Secondary Prevention of ASCVD

A 64-year-old woman with a significant medical history sees her cardiologist for a routine follow-up after a second MI. How do you minimize her risk for future ASCVD events?American College of Cardiology & Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Clinical Case Source Type: news